TELO
NASDAQ
$0.92
Telomir Pharmaceuticals Inc (TELO)
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Target: $15.50 (+1586.25%)
Market Cap
$46M
Free Cash Flow Yield
-8.07%
Beta (5Y)
1.40
Price Chart
Valuation
Market Cap$46M
P/B7.38
Profitability
EBITDA-$10M
EPS-$0.33
Financial Health
Free Cash Flow Yield-8.07%
Growth & Risk
Beta (5Y)1.40
Sharpe Ratio0.19